Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Plos Medicine|June 29, 2016
The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled TrialJun-Ichi Oyama, Toyoaki Murohara, Masafumi Kitakaze, et al.
Journal of the American Heart Association|December 12, 2019
Brachial-Ankle Pulse Wave Velocity Versus Its Stiffness Index β-Transformed Value as Risk Marker for Cardiovascular DiseaseHirofumi Tomiyama, Toshiaki Ohkuma, Toshiharu Ninomiya, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 18, 2025
Effect of Tofogliflozin on Urinary Albumin-to-Creatinine Ratio vs. Metformin in Diabetic Kidney Disease: Rationale and Study Protocol of the TRUTH-DKD TrialKazuhiro Kimura, Yoshiko Takagi, Makoto Harada, et al.
Journal of Atherosclerosis and Thrombosis|November 5, 2023
Role of Small Dense Low-density Lipoprotein Cholesterol in Cardiovascular Events in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Receiving Statin TreatmentTakayuki Yamaji, Takahiro Harada, Masato Kajikawa, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2024
Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in JapanTsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Clinical and Molecular Hepatology|January 24, 2024
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE studyMichihiro Iwaki, Hideki Fujii, Hideki Hayashi, et al.
Journal of Gastroenterology and Hepatology|February 17, 2023
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia studyHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2022
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort StudyHideki Fujii, Michihiro Iwaki, Hideki Hayashi, et al.
Gastro Hep Advances|June 11, 2025
Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7SHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Gastro Hep Advances|August 12, 2024
Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLDHidenori Toyoda, Hideki Fujii, Michihiro Iwaki, et al.
Pageof 16